Search Results for: International Stem Cell Corporation to
Articles
International Stem Cell Corporation to Expand its Revenue-Generating Biomedical Businesses to Support Ongoing & Future Clinical Trials October 2, 2017
International Stem Cell Corporation recently announced that ISCO’s wholly owned subsidiaries Lifeline Cell Technology (LCT) and Lifeline Skin Care (LSC)...International Stem Cell Corporation Developed 3D Liver Structures August 13, 2018
International Stem Cell Corporation recently announced that ISCO’s Research and Development team has developed novel methods that efficiently generate human...International Stem Cell Corporation Completes Dosing of Second Cohort in Parkinson's Disease Trial March 16, 2018
International Stem Cell Corporation recently announced the eighth participant, which completes the dosing of the second cohort of the clinical...International Stem Cell Corporation Completes Dosing of Second Cohort in Parkinson's Disease Trial March 13, 2018
International Stem Cell Corporation recently announced the eighth participant, which completes the dosing of the second cohort of the clinical...International Stem Cell Corporation Announces Third Patient With Parkinson's Disease in Clinical Trial March 6, 2017
International Stem Cell Corporation recently announced the third patient in the clinical trial for Parkinson's Disease was successfully transplanted with...Pharmaceutics International, Inc. Onboards New Leadership Team to Drive Quality, Operational Improvements & Growth March 20, 2023
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), recently announced the formation of a new leadership team...Genelux Corporation Initiates Pivotal Phase 3 Trial Evaluating Olvi-Vec for the Treatment of Platinum-Resistant/Refractory Ovarian Cancer September 21, 2022
Genelux Corporation recently announced it has initiated OnPrime, a multi-center, randomized, open-label Phase 3 registrational trial evaluating the efficacy and...Celsion Reports T-cell & B-cell Response From In Vivo Studies With its PLACCINE DNA Vaccine Platform September 8, 2021
Celsion Corporation recently announced results from preclinical in vivo studies showing production of antibodies and cytotoxic T-cell response specific to...International Stem Cell Completes Enrollment & Dosing in its Parkinson's Disease Clinical Trial May 2, 2019
International Stem Cell Corporation recently announced the completion of subject enrollment in its Phase 1 clinical trial of ISC-hpNSC for...LIPID-BASED DELIVERY - Are Lipid-Based Drug Delivery Systems in Your Formulation Toolbox? September 29, 2017
Jason M. LePree, RPh, PhD, reviews the causes of poor bioavailability for drugs and provides an introduction to lipid-based drug delivery systems, and how the formulation approach can be used to overcome impediments to good bioavailability of therapeutic actives.
Downstream Processing - BioProcess International Conference Pre-Event Podcast Series September 10, 2015
Hear talk previews from Recovery & Purification + Analytcal, Quality, and Formulations speakers Characterization of Host-Cell Proteins Using Mass...R-Tech Ueno to Collaborative With Tohoku University on New Delivery System July 19, 2012
R-Tech Ueno recently announced it will conduct a collaborative study with Tohoku University, a national university corporation, to develop a...SPECIAL FEATURE - Outsourcing Analytical Testing: AI Could Transform Analytical Labs January 29, 2024
Contributor Cindy H. Dubin presents how today’s leading analytical testing service providers are taking advantage of AI and other types of automation and innovative technologies.
Aptamers Market is Expected to Reach $342 million April 27, 2023
The aptamers industry has been growing steadily in recent years, and is expected to continue to do so in the...Absci Expands in Europe With Launch of New Innovation Center & Additional Senior Leadership in Switzerland February 28, 2023
Absci Corporation recently announced its expansion into the European pharmaceutical market with the opening of its Innovation Center, located in...DISCOVERY PLATFORM - Reverse-Engineering Targeted Immunotherapy January 16, 2023
Bob Lechleider, MD, explains how by applying a patient-first technology and looking for clues in the immune system, a powerful tool can be harnessed – the human body – to identify and produce new molecules to make medicines for cancer patients.
FORMULATION DEVELOPMENT - Understanding CBD Formulation Versus Dosage Format January 16, 2023
Gerry McNally, PhD, says there are many misconceptions when it comes to considering the best way or format to consume CBD and get the maximum benefit. Formulation scientists need to consider several factors when developing new formulations of nutraceutical ingredients, especially botanical ingredients and natural materials from various sources.
Chiesi Global Rare Diseases Announces FDA Acceptance of BLA Filing for the Proposed Treatment of Alpha-Mannosidosis September 12, 2022
Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., recently announced the US FDA has accepted the Biologics...SPECIAL ROUNDTABLE - Which Trends Will Have the Most Impact on Drug Development in 2022? June 6, 2022
Drug Development & Delivery posed this question to life science leaders during a recent roundtable discussion. While their responses are varied, a common theme is that COVID-19 has left a lasting impact on the industry….
SPECIAL FEATURE - PFS & Parenteral Drug Delivery: Self-Injection is Very Much the “New Normal” May 2, 2022
Contributor Cindy H. Dubin showcases how leading CDMOs and drug delivery developers are responding to current market trends to create ergonomic technologies that are patient friendly, easy to use, reduce needle anxiety, and feature improved packaging materials.
